Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer

The association between Epstein-Barr virus (EBV) and the development of head and neck cancer was reported by many researchers. The aim of the present study was to detect EBV DNA and EBV antibodies in 110 Polish patients with oropharyngeal and laryngeal cancer compared to 40 healthy individuals. Froz...

Full description

Saved in:
Bibliographic Details
Published in:Infectious agents and cancer 2017-05, Vol.12 (1), p.31-31, Article 31
Main Authors: Fołtyn, Sylwia, Strycharz-Dudziak, Małgorzata, Drop, Bartłomiej, Boguszewska, Anastazja, Polz-Dacewicz, Małgorzata
Format: Article
Language:English
Subjects:
Alcohol
Antibodies
Antigens
Deoxyribonucleic acid
DNA
EBV antibodies
Enzyme-linked immunosorbent assay
Epstein-Barr virus
Gastric cancer
Gene expression
Head & neck cancer
Immunoglobulin G
Immunoglobulin M
Immunoglobulins
Infections
Laryngeal cancer
Larynx
LMP1
Lymphoma
Oropharyngeal cancer
Otolaryngology
Polymerase chain reaction
Throat cancer
Viral infections
Viruses
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c493t-85f34687b20bbb3b8169b651683abd1601de0a822f5d18337142bd860213b7ca3
cites cdi_FETCH-LOGICAL-c493t-85f34687b20bbb3b8169b651683abd1601de0a822f5d18337142bd860213b7ca3
container_end_page 31
container_issue 1
container_start_page 31
container_title Infectious agents and cancer
container_volume 12
creator Fołtyn, Sylwia
Strycharz-Dudziak, Małgorzata
Drop, Bartłomiej
Boguszewska, Anastazja
Polz-Dacewicz, Małgorzata
description The association between Epstein-Barr virus (EBV) and the development of head and neck cancer was reported by many researchers. The aim of the present study was to detect EBV DNA and EBV antibodies in 110 Polish patients with oropharyngeal and laryngeal cancer compared to 40 healthy individuals. Frozen tumor tissue fragments were tested using nested PCR assay for EBV DNA detection. Sera from all individuals were investigated using ELISA tests to detect the presence of VCA IgM and IgG, EBNA IgG, EA IgG. EBV DNA was detected in 52.7% of the patients (25% in controls). EBVCA were detected in 94.5%, EBNA in 96.4% and EA in 94.5% of patients. The significantly higher level of EA in the patients suggests EBV reactivation. The majority of patients (83%) were infected with wild-type EBV. Our study showed that this variant seems to be associated with oropharyngeal and laryngeal cancer in the Polish population.
doi_str_mv 10.1186/s13027-017-0141-x
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c57d4cfc9c4a4890abc8797cd401b5ea</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c57d4cfc9c4a4890abc8797cd401b5ea</doaj_id><sourcerecordid>1905586758</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-85f34687b20bbb3b8169b651683abd1601de0a822f5d18337142bd860213b7ca3</originalsourceid><addsrcrecordid>eNpdkk1v1DAQhiMEoqXwA7igSFy4BDz-iCcXJKgKVFpEJT4kTpa_sutVNt7aCZR_j3e3rFoOlmfsZ17N2G9VPQfyGgDbNxkYobIhsFscmpsH1SlIQZqOSXx4Jz6pnuS8JoQjRXxcnVAUkiKTp9XPrz7Nm_ri_Y9aj1Mw0QWfS-jqxeerBuow1ldxCHlVb_UU_Djl-neYVnVMcbvS6c-49HrY88Mxs3q0Pj2tHvV6yP7Z7X5Wff9w8e38U7P48vHy_N2isbxjU4OiZ7xFaSgxxjCD0HamFdAi08ZBS8B5opHSXjhAxiRwahy2hAIz0mp2Vl0edF3Ua7VNYVMaUVEHtT-Iaal0moIdvLJCOm5721muOXZEG4uyk9ZxAkb4ndbbg9Z2NhvvbJk36eGe6P2bMazUMv5SggvCsCsCr24FUryefZ7UJmTrh0GPPs5ZQUeEZJJKWdCX_6HrOKexPNWeEthKgYWCA2VTzDn5_tgMELUzgTqYQBUTqJ0J1E2peXF3imPFv19nfwGk0qzJ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1905586758</pqid></control><display><type>article</type><title>Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Fołtyn, Sylwia ; Strycharz-Dudziak, Małgorzata ; Drop, Bartłomiej ; Boguszewska, Anastazja ; Polz-Dacewicz, Małgorzata</creator><creatorcontrib>Fołtyn, Sylwia ; Strycharz-Dudziak, Małgorzata ; Drop, Bartłomiej ; Boguszewska, Anastazja ; Polz-Dacewicz, Małgorzata</creatorcontrib><description>The association between Epstein-Barr virus (EBV) and the development of head and neck cancer was reported by many researchers. The aim of the present study was to detect EBV DNA and EBV antibodies in 110 Polish patients with oropharyngeal and laryngeal cancer compared to 40 healthy individuals. Frozen tumor tissue fragments were tested using nested PCR assay for EBV DNA detection. Sera from all individuals were investigated using ELISA tests to detect the presence of VCA IgM and IgG, EBNA IgG, EA IgG. EBV DNA was detected in 52.7% of the patients (25% in controls). EBVCA were detected in 94.5%, EBNA in 96.4% and EA in 94.5% of patients. The significantly higher level of EA in the patients suggests EBV reactivation. The majority of patients (83%) were infected with wild-type EBV. Our study showed that this variant seems to be associated with oropharyngeal and laryngeal cancer in the Polish population.</description><identifier>ISSN: 1750-9378</identifier><identifier>EISSN: 1750-9378</identifier><identifier>DOI: 10.1186/s13027-017-0141-x</identifier><identifier>PMID: 28572837</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>Alcohol ; Antibodies ; Antigens ; Deoxyribonucleic acid ; DNA ; EBV antibodies ; Enzyme-linked immunosorbent assay ; Epstein-Barr virus ; Gastric cancer ; Gene expression ; Head &amp; neck cancer ; Immunoglobulin G ; Immunoglobulin M ; Immunoglobulins ; Infections ; Laryngeal cancer ; Larynx ; LMP1 ; Lymphoma ; Oropharyngeal cancer ; Otolaryngology ; Polymerase chain reaction ; Throat cancer ; Viral infections ; Viruses</subject><ispartof>Infectious agents and cancer, 2017-05, Vol.12 (1), p.31-31, Article 31</ispartof><rights>Copyright BioMed Central 2017</rights><rights>The Author(s). 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-85f34687b20bbb3b8169b651683abd1601de0a822f5d18337142bd860213b7ca3</citedby><cites>FETCH-LOGICAL-c493t-85f34687b20bbb3b8169b651683abd1601de0a822f5d18337142bd860213b7ca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450389/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1905586758?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28572837$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fołtyn, Sylwia</creatorcontrib><creatorcontrib>Strycharz-Dudziak, Małgorzata</creatorcontrib><creatorcontrib>Drop, Bartłomiej</creatorcontrib><creatorcontrib>Boguszewska, Anastazja</creatorcontrib><creatorcontrib>Polz-Dacewicz, Małgorzata</creatorcontrib><title>Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer</title><title>Infectious agents and cancer</title><addtitle>Infect Agent Cancer</addtitle><description>The association between Epstein-Barr virus (EBV) and the development of head and neck cancer was reported by many researchers. The aim of the present study was to detect EBV DNA and EBV antibodies in 110 Polish patients with oropharyngeal and laryngeal cancer compared to 40 healthy individuals. Frozen tumor tissue fragments were tested using nested PCR assay for EBV DNA detection. Sera from all individuals were investigated using ELISA tests to detect the presence of VCA IgM and IgG, EBNA IgG, EA IgG. EBV DNA was detected in 52.7% of the patients (25% in controls). EBVCA were detected in 94.5%, EBNA in 96.4% and EA in 94.5% of patients. The significantly higher level of EA in the patients suggests EBV reactivation. The majority of patients (83%) were infected with wild-type EBV. Our study showed that this variant seems to be associated with oropharyngeal and laryngeal cancer in the Polish population.</description><subject>Alcohol</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>EBV antibodies</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Epstein-Barr virus</subject><subject>Gastric cancer</subject><subject>Gene expression</subject><subject>Head &amp; neck cancer</subject><subject>Immunoglobulin G</subject><subject>Immunoglobulin M</subject><subject>Immunoglobulins</subject><subject>Infections</subject><subject>Laryngeal cancer</subject><subject>Larynx</subject><subject>LMP1</subject><subject>Lymphoma</subject><subject>Oropharyngeal cancer</subject><subject>Otolaryngology</subject><subject>Polymerase chain reaction</subject><subject>Throat cancer</subject><subject>Viral infections</subject><subject>Viruses</subject><issn>1750-9378</issn><issn>1750-9378</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkk1v1DAQhiMEoqXwA7igSFy4BDz-iCcXJKgKVFpEJT4kTpa_sutVNt7aCZR_j3e3rFoOlmfsZ17N2G9VPQfyGgDbNxkYobIhsFscmpsH1SlIQZqOSXx4Jz6pnuS8JoQjRXxcnVAUkiKTp9XPrz7Nm_ri_Y9aj1Mw0QWfS-jqxeerBuow1ldxCHlVb_UU_Djl-neYVnVMcbvS6c-49HrY88Mxs3q0Pj2tHvV6yP7Z7X5Wff9w8e38U7P48vHy_N2isbxjU4OiZ7xFaSgxxjCD0HamFdAi08ZBS8B5opHSXjhAxiRwahy2hAIz0mp2Vl0edF3Ua7VNYVMaUVEHtT-Iaal0moIdvLJCOm5721muOXZEG4uyk9ZxAkb4ndbbg9Z2NhvvbJk36eGe6P2bMazUMv5SggvCsCsCr24FUryefZ7UJmTrh0GPPs5ZQUeEZJJKWdCX_6HrOKexPNWeEthKgYWCA2VTzDn5_tgMELUzgTqYQBUTqJ0J1E2peXF3imPFv19nfwGk0qzJ</recordid><startdate>20170530</startdate><enddate>20170530</enddate><creator>Fołtyn, Sylwia</creator><creator>Strycharz-Dudziak, Małgorzata</creator><creator>Drop, Bartłomiej</creator><creator>Boguszewska, Anastazja</creator><creator>Polz-Dacewicz, Małgorzata</creator><general>BioMed Central</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170530</creationdate><title>Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer</title><author>Fołtyn, Sylwia ; Strycharz-Dudziak, Małgorzata ; Drop, Bartłomiej ; Boguszewska, Anastazja ; Polz-Dacewicz, Małgorzata</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-85f34687b20bbb3b8169b651683abd1601de0a822f5d18337142bd860213b7ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Alcohol</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>EBV antibodies</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Epstein-Barr virus</topic><topic>Gastric cancer</topic><topic>Gene expression</topic><topic>Head &amp; neck cancer</topic><topic>Immunoglobulin G</topic><topic>Immunoglobulin M</topic><topic>Immunoglobulins</topic><topic>Infections</topic><topic>Laryngeal cancer</topic><topic>Larynx</topic><topic>LMP1</topic><topic>Lymphoma</topic><topic>Oropharyngeal cancer</topic><topic>Otolaryngology</topic><topic>Polymerase chain reaction</topic><topic>Throat cancer</topic><topic>Viral infections</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fołtyn, Sylwia</creatorcontrib><creatorcontrib>Strycharz-Dudziak, Małgorzata</creatorcontrib><creatorcontrib>Drop, Bartłomiej</creatorcontrib><creatorcontrib>Boguszewska, Anastazja</creatorcontrib><creatorcontrib>Polz-Dacewicz, Małgorzata</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Infectious agents and cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fołtyn, Sylwia</au><au>Strycharz-Dudziak, Małgorzata</au><au>Drop, Bartłomiej</au><au>Boguszewska, Anastazja</au><au>Polz-Dacewicz, Małgorzata</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer</atitle><jtitle>Infectious agents and cancer</jtitle><addtitle>Infect Agent Cancer</addtitle><date>2017-05-30</date><risdate>2017</risdate><volume>12</volume><issue>1</issue><spage>31</spage><epage>31</epage><pages>31-31</pages><artnum>31</artnum><issn>1750-9378</issn><eissn>1750-9378</eissn><abstract>The association between Epstein-Barr virus (EBV) and the development of head and neck cancer was reported by many researchers. The aim of the present study was to detect EBV DNA and EBV antibodies in 110 Polish patients with oropharyngeal and laryngeal cancer compared to 40 healthy individuals. Frozen tumor tissue fragments were tested using nested PCR assay for EBV DNA detection. Sera from all individuals were investigated using ELISA tests to detect the presence of VCA IgM and IgG, EBNA IgG, EA IgG. EBV DNA was detected in 52.7% of the patients (25% in controls). EBVCA were detected in 94.5%, EBNA in 96.4% and EA in 94.5% of patients. The significantly higher level of EA in the patients suggests EBV reactivation. The majority of patients (83%) were infected with wild-type EBV. Our study showed that this variant seems to be associated with oropharyngeal and laryngeal cancer in the Polish population.</abstract><cop>England</cop><pub>BioMed Central</pub><pmid>28572837</pmid><doi>10.1186/s13027-017-0141-x</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1750-9378
ispartof Infectious agents and cancer, 2017-05, Vol.12 (1), p.31-31, Article 31
issn 1750-9378
1750-9378
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_c57d4cfc9c4a4890abc8797cd401b5ea
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central
subjects Alcohol
Antibodies
Antigens
Deoxyribonucleic acid
DNA
EBV antibodies
Enzyme-linked immunosorbent assay
Epstein-Barr virus
Gastric cancer
Gene expression
Head & neck cancer
Immunoglobulin G
Immunoglobulin M
Immunoglobulins
Infections
Laryngeal cancer
Larynx
LMP1
Lymphoma
Oropharyngeal cancer
Otolaryngology
Polymerase chain reaction
Throat cancer
Viral infections
Viruses
title Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T11%3A21%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20EBV%20antibodies%20and%20LMP-1%20in%20Polish%20patients%20with%20oropharyngeal%20and%20laryngeal%20cancer&rft.jtitle=Infectious%20agents%20and%20cancer&rft.au=Fo%C5%82tyn,%20Sylwia&rft.date=2017-05-30&rft.volume=12&rft.issue=1&rft.spage=31&rft.epage=31&rft.pages=31-31&rft.artnum=31&rft.issn=1750-9378&rft.eissn=1750-9378&rft_id=info:doi/10.1186/s13027-017-0141-x&rft_dat=%3Cproquest_doaj_%3E1905586758%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c493t-85f34687b20bbb3b8169b651683abd1601de0a822f5d18337142bd860213b7ca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1905586758&rft_id=info:pmid/28572837&rfr_iscdi=true